Patents by Inventor Christopher C. Dick

Christopher C. Dick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Abuse resistant oral dosage forms
    Patent number: 10213388
    Abstract: Aspects of the present invention are directed to abuse resistant oral dosage forms comprising a compressed microtablet that is coated with a water-retardant polymer. Additional aspects of the present invention are directed to an oral dosage form comprising an opioid agonist and at least one compressed microtablet coated with a water retardant polymer. The compressed microtablet may comprise an opioid antagonist.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: February 26, 2019
    Assignee: Elite Laboratories, Inc.
    Inventors: Christopher C. Dick, David F. Erkoboni, Charanjit R. Behl, Gary Bubb
  • Abuse Resistant Oral Dosage Forms
    Publication number: 20150250732
    Abstract: Aspects of the present invention are directed to abuse resistant oral dosage forms comprising a compressed microtablet that is coated with a water-retardant polymer. Additional aspects of the present invention are directed to an oral dosage form comprising an opioid agonist and at least one compressed microtablet coated with a water retardant polymer. The compressed microtablet may comprise an opioid antagonist.
    Type: Application
    Filed: May 18, 2015
    Publication date: September 10, 2015
    Inventors: Christopher C. Dick, David F. Erkoboni, Charanjit R. Behl, Gary Bubb
  • Abuse resistant oral dosage forms
    Patent number: 9056054
    Abstract: Aspects of the present invention are directed to abuse resistant oral dosage forms comprising a compressed microtablet that is coated with a water-retardant polymer. Additional aspects of the present invention are directed to an oral dosage form comprising an opioid agonist and at least one compressed microtablet coated with a water retardant polymer. The compressed microtablet may comprise an opioid antagonist.
    Type: Grant
    Filed: June 25, 2010
    Date of Patent: June 16, 2015
    Assignee: Elite Laboratories, Inc.
    Inventors: Christopher C. Dick, David F. Erkoboni, Charanjit R. Behl, Gary Bubb
  • ABUSE RESISTANT ORAL DOSAGE FORMS
    Publication number: 20130084333
    Abstract: Aspects of the present invention are directed to abuse resistant oral dosage forms comprising a compressed microtablet that is coated with a water-retardant polymer. Additional aspects of the present invention are directed to an oral dosage form comprising an opioid agonist and at least one compressed microtablet coated with a water retardant polymer. The compressed microtablet may comprise an opioid antagonist.
    Type: Application
    Filed: June 25, 2010
    Publication date: April 4, 2013
    Applicant: ELITE LABORATORIES, INC
    Inventors: Christopher C. Dick, David F. Erkoboni, Charanjit R. Behl, Gary Bubb
  • ORAL DOSAGE FORMS
    Publication number: 20120189693
    Abstract: Aspects of the present invention are directed to oral dosage forms comprising a compressed microtablet, wherein said microtablet has a major dimension that is between about 0.25 mm and about 1.0 mm and comprises at least about 0.01 weight percent of at least one pharmaceutically active agent that is distributed substantially throughout said microtablet. Additional aspects of the present invention are directed to methods for producing compressed microtablets having a major dimension that is between about 0.25 mm and about 1.0 mm.
    Type: Application
    Filed: June 25, 2010
    Publication date: July 26, 2012
    Applicant: Elite Laboratories, Inc.
    Inventors: Christopher C. Dick, David F. Erkoboni, Charanjit R. Behl, Gary Bubb